MilliporeSigma
MilliporeSigma
Simtra BioPharma’s Bold Global Expansion: What’s Next?
Simtra BioPharma is expanding globally! 🌍 With $500M investments, they enhance production for life-saving therapies. 🚀🤝 HealthcareInnovation
MilliporeSigma Boosts Bioprocessing with JSR Acquisition!
MilliporeSigma is acquiring JSR Life Sciences' chromatography business! 🚀 This deal boosts bioprocessing for monoclonal antibodies. 💉✨
Revolutionizing Antibody Manufacturing: Simtra and MilliporeSigma Team Up!
🚀 Simtra BioPharma Solutions and MilliporeSigma join forces! 💊 Their partnership enhances antibody drug conjugate manufacturing for better patient access. 🤝✨
MilliporeSigma Boosts Cancer Treatment with $76M Investment!
MilliporeSigma invests $76M to triple ADC manufacturing capacity! 🌟 Accelerating new cancer therapies for better patient outcomes. 📈💊
Revolutionary $286M Lab Set to Transform Biotech!
🌟 MilliporeSigma opens a $286M biosafety testing facility in Maryland, boosting global medicine safety and creating 300 new jobs! 🏛️👩🔬🔍
MilliporeSigma Boosts Gene Therapy with $600M Acquisition!
MilliporeSigma acquires Mirus Bio for $600 million, boosting viral vector manufacturing and supporting gene therapy advancements! 🚀🔬💡🤝
MilliporeSigma Acquires Mirus Bio for $600 Million Expanding in Gene Therapy Market
MilliporeSigma 💪 powers up with $600M acquisition of Mirus Bio! 📆 Closing in Q3 2024. 😮 CellAndGeneTherapy BiotechNews
MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬
